ArticleBMC ophthalmology2015

One year results of intravitreal ranibizumab monotherapy for retinal angiomatous proliferation: a comparative analysis based on disease stages.

Young Gun Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.